Navidea’s Lymph Node Mapping Agent Clears FDA; U.S. Distributor Cardinal Health To Split Revenue
This article was originally published in The Pink Sheet Daily
Navidea’s Lymphoseek is for use in identifying lymph nodes most likely to harbor cancer in patients with breast cancer and melanoma; the firm hopes for a broader indication in Europe and is working to identify distributors in markets outside the U.S.
You may also be interested in...
Novartis co-leads industry forum on preapproval access that aims to share best practices and engage patient groups; Janssen is launching three pilots to leverage collection of preapproval access data.
FDA is worried about drug names that could appear to overstate efficacy and impact consumer and healthcare provider perceptions of the product.
Emergence of the inter partes review process dramatically changed the patent dispute arena. The decade also brought biosimilar litigation, generic price-fixing complaints, opioid lawsuits and new government investigations and antitrust actions.